文献速递细菌感染、耐药与抗菌药物医院感染防控

皮下注射抗生素的适用时机与使用方法

When and How to Use Subcutaneous Antibiotics.
PubMed 文献 · Clin Infect Dis · 2026-01-01

本文综述皮下抗生素给药在静脉通路困难、衰弱或门诊/姑息治疗患者中的应用。β-内酰胺类(如头孢曲松、厄他培南)和糖肽类(如替考拉宁)可达到与静脉给药相当的治疗药代/药效学(PK/PD)目标;氨基糖苷类和氟喹诺酮类因峰浓度降低和局部毒性而PK/PD获益有限,达托霉素暴露和靶目标达成良好。总体耐受性良好,但监管框架仍有限。

要点

  • 皮下抗生素适用于静脉通路差、衰弱或门诊/姑息治疗且口服不可行的患者。
  • 时间依赖性抗生素(如头孢曲松、厄他培南、替考拉宁)皮下给药可达与静脉相当的PK/PD目标。
  • 氨基糖苷类和氟喹诺酮类皮下给药PK/PD获益有限,达托霉素暴露和靶目标达成良好。

核心结论

  • 皮下抗生素给药是特定临床情境下静脉治疗的可行替代方案,总体耐受性良好但监管框架有限。

研究设计与样本

  • 由感染病专家、临床药理学家和护士共同撰写的多学科综述,总结当前临床经验、PK/PD数据及皮下输注技术方面。

主要发现

  • 对静脉通路差、衰弱或恶病质患者及门诊或姑息治疗中口服不可行时,皮下给药尤其有优势。
  • 时间依赖性抗生素(如头孢曲松、厄他培南等β-内酰胺类及替考拉宁等糖肽类)皮下给药可达与静脉给药相当的治疗PK/PD目标,浓度稳定并减少导管相关并发症。
  • 氨基糖苷类和氟喹诺酮类因峰浓度降低和局部毒性,PK/PD获益有限;达托霉素显示良好暴露和靶目标达成且耐受性可接受。

临床怎么用

  • 对静脉通路困难、衰弱或门诊/姑息治疗且口服不可行的患者,可考虑皮下给予时间依赖性抗生素(如头孢曲松、厄他培南、替考拉宁)。
  • 氨基糖苷类和氟喹诺酮类皮下给药PK/PD获益有限,达托霉素可考虑用于皮下给药。

局限性

  • 监管框架仍有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Subcutaneous antibiotic administration is increasingly recognized as a valuable alternative to intravenous therapy in selected clinical contexts. It is particularly advantageous for patients with poor venous access, frail or cachectic individuals, and in outpatient or palliative care settings, when oral options are not feasible. Subcutaneous delivery of antibiotics with predominantly time-dependent activity, particularly β-lactams (eg ceftriaxone, ertapenem) and glycopeptides (teicoplanin), allows attainment of therapeutic pharmacokinetic/pharmacodynamic (PK/PD) targets comparable to intravenous administration, while maintaining stable concentrations and reducing catheter-related complications. By contrast, PK/PD benefits are limited for agents with more concentration-dependent activity, such as aminoglycosides and fluoroquinolones due to reduced peak levels and local toxicity, whereas daptomycin shows favorable exposure and target attainment with acceptable tolerability. Available evidence suggests good tolerability, although regulatory frameworks remain limited. This multidisciplinary review, authored by infectious disease specialists, clinical pharmacologists, and nurses, summarizes current clinical experience, PK/PD data, and technical aspects of subcutaneous infusion.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Di Bella S, Geremia N, Pea F, et al. When and How to Use Subcutaneous Antibiotics. Clin Infect Dis. 2026. PMID: 41556663. doi:10.1093/cid/ciaf691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。